Put Options

7 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2021

Nov 15, 2021

SELL
$372.64 - $458.3 $9.69 Million - $11.9 Million
-26,000 Closed
0 $0
Q2 2021

Aug 20, 2021

SELL
$294.17 - $371.65 $757 Million - $957 Million
-2,574,000 Reduced 99.0%
26,000 $9.62 Million
Q2 2021

Aug 16, 2021

BUY
$294.17 - $371.65 $757 Million - $957 Million
2,574,000 Added 9900.0%
2,600,000 $9.62 Million
Q1 2021

Sep 21, 2023

BUY
$249.67 - $299.48 $249,670 - $299,480
1,000 Added 4.0%
26,000 $7.54 Million
Q1 2021

May 14, 2021

BUY
$249.67 - $299.48 $249,670 - $299,480
1,000 Added 4.0%
26,000 $7.54 Million
Q4 2020

Sep 21, 2023

BUY
$222.0 - $252.62 $5.55 Million - $6.32 Million
25,000 New
25,000 $6.25 Million
Q4 2020

Feb 16, 2021

BUY
$222.0 - $252.62 $5.55 Million - $6.32 Million
25,000 New
25,000 $6.25 Million

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $10.2B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Jefferies Group LLC Portfolio

Follow Jefferies Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jefferies Group LLC with notifications on news.